The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
Marina Pontello CristelliRonaldo Matos EsmeraldoCahue Motta PintoTainá Veras de Sanders FreitasClaudia FelipeClarissa Ferreira LoboLaila VianaJuliana MansurSuelen StopaDaniel Wagner Castro SantosPatricia Cristina GrenziWilson Ferreira AguiarHelio Tedesco-SilvaJose Osmar Medina PestanaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
In this cohort of high-risk CMV D+/R- kidney transplant recipients receiving rATG induction and tacrolimus, the use of mTOR inhibitors could only show a tendency towards but not a significant difference on the incidence of CMV events, when compared to antimetabolites.
Keyphrases